NO20076161L - Fremgangsmater for fremstilling av 4-bifenylazetidin-2-oner - Google Patents
Fremgangsmater for fremstilling av 4-bifenylazetidin-2-onerInfo
- Publication number
- NO20076161L NO20076161L NO20076161A NO20076161A NO20076161L NO 20076161 L NO20076161 L NO 20076161L NO 20076161 A NO20076161 A NO 20076161A NO 20076161 A NO20076161 A NO 20076161A NO 20076161 L NO20076161 L NO 20076161L
- Authority
- NO
- Norway
- Prior art keywords
- biphenylazetidin
- ones
- preparing
- methods
- biphenylylazetidin
- Prior art date
Links
- BVRQCFAKNTVTBZ-UHFFFAOYSA-N 4-(2-phenylphenyl)azetidin-2-one Chemical class N1C(=O)CC1C1=CC=CC=C1C1=CC=CC=C1 BVRQCFAKNTVTBZ-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C211/54—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to two or three six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/02—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
- C07C251/24—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to carbon atoms of six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/26—Oxygen atoms attached in position 2 with hetero atoms or acyl radicals directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
- C07F7/1872—Preparation; Treatments not provided for in C07F7/20
- C07F7/1892—Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67833605P | 2005-05-06 | 2005-05-06 | |
| US72692905P | 2005-10-14 | 2005-10-14 | |
| PCT/US2006/017706 WO2006122020A2 (en) | 2005-05-06 | 2006-05-08 | Process for production of 4-biphenylyazetidin-2-ones |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20076161L true NO20076161L (no) | 2007-11-29 |
Family
ID=37101971
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20076161A NO20076161L (no) | 2005-05-06 | 2007-11-29 | Fremgangsmater for fremstilling av 4-bifenylazetidin-2-oner |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20080287663A1 (ru) |
| EP (1) | EP1893571A2 (ru) |
| JP (1) | JP2008542205A (ru) |
| KR (1) | KR20080011687A (ru) |
| AU (1) | AU2006244212A1 (ru) |
| BR (1) | BRPI0611045A2 (ru) |
| CA (1) | CA2607939A1 (ru) |
| EA (1) | EA200702428A1 (ru) |
| IL (1) | IL187155A0 (ru) |
| MA (1) | MA29496B1 (ru) |
| MX (1) | MX2007013872A (ru) |
| NO (1) | NO20076161L (ru) |
| TW (1) | TW200726746A (ru) |
| WO (1) | WO2006122020A2 (ru) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2608108A1 (en) * | 2005-05-09 | 2006-11-16 | Microbia, Inc. | Organometal benzenephosphonate coupling agents |
| KR20080017345A (ko) * | 2005-05-11 | 2008-02-26 | 마이크로비아 인코포레이티드 | 페놀성 4-비페닐일아제티딘-2-온의 제조방법 |
| EA200702614A1 (ru) * | 2005-05-25 | 2008-04-28 | Майкробиа, Инк. | Способы получения 4-(бифенилил)азетидин-2-оналкилфосфиновых кислот |
| WO2008061238A2 (en) * | 2006-11-16 | 2008-05-22 | Ironwood Pharmaceuticals, Inc. | Processes for production of 4-biphenylyazetidin-2-ones |
| CN101993403B (zh) * | 2009-08-11 | 2012-07-11 | 浙江海正药业股份有限公司 | 氮杂环丁酮类化合物及医药应用 |
| US9193751B2 (en) | 2012-04-10 | 2015-11-24 | Theracos, Inc. | Process for the preparation of benzylbenzene SGLT2 inhibitors |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3794734A (en) | 1971-03-03 | 1974-02-26 | Merck & Co Inc | Methods of treating edema and hypertension using certain 2-aminoethylphenols |
| US5561227A (en) * | 1991-07-23 | 1996-10-01 | Schering Corporation | Process for the stereospecific synthesis of azetidinones |
| US5688787A (en) * | 1991-07-23 | 1997-11-18 | Schering Corporation | Substituted β-lactam compounds useful as hypochlesterolemic agents and processes for the preparation thereof |
| ES2107548T3 (es) * | 1991-07-23 | 1997-12-01 | Schering Corp | Compuestos de beta-lactama sustituidos utiles como agentes hipocolesterolemicos y procedimientos para su preparacion. |
| US5631365A (en) * | 1993-09-21 | 1997-05-20 | Schering Corporation | Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
| CA2158191A1 (en) * | 1994-09-16 | 1996-03-17 | Junji Yokoi | Method for preventing settlement of aquatic fouling organisms |
| US5656624A (en) * | 1994-12-21 | 1997-08-12 | Schering Corporation | 4-[(heterocycloalkyl or heteroaromatic)-substituted phenyl]-2-azetidinones useful as hypolipidemic agents |
| US5756470A (en) * | 1996-10-29 | 1998-05-26 | Schering Corporation | Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents |
| US6077850A (en) * | 1997-04-21 | 2000-06-20 | G.D. Searle & Co. | Substituted benzopyran analogs for the treatment of inflammation |
| US6207822B1 (en) * | 1998-12-07 | 2001-03-27 | Schering Corporation | Process for the synthesis of azetidinones |
| JP3640888B2 (ja) * | 1998-12-07 | 2005-04-20 | シェーリング コーポレイション | アゼチジノンの合成プロセス |
| PH12000002657B1 (en) * | 1999-10-12 | 2006-02-21 | Bristol Myers Squibb Co | C-aryl glucoside SGLT2 inhibitors |
| IL156552A0 (en) * | 2000-12-21 | 2004-01-04 | Aventis Pharma Gmbh | Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use |
| BR0116325A (pt) | 2000-12-21 | 2003-10-14 | Aventis Pharma Gmbh | 1,2-difenilazetidinonas, processos para a sua preparação, medicamentos contendo estes compostos e sua aplicação para o tratamento de distúrbios do metabolismo de lipìdios |
| TWI291957B (en) * | 2001-02-23 | 2008-01-01 | Kotobuki Pharmaceutical Co Ltd | Beta-lactam compounds, process for repoducing the same and serum cholesterol-lowering agents containing the same |
| DK1373230T3 (da) * | 2001-03-28 | 2005-11-07 | Schering Corp | Enantiselektiv syntese af azetidinon mellemprodukter |
| TWI254635B (en) * | 2002-08-05 | 2006-05-11 | Yamanouchi Pharma Co Ltd | Azulene derivative and salt thereof |
| EP1626954A2 (en) * | 2003-05-05 | 2006-02-22 | Ranbaxy Laboratories, Ltd. | Process for the preparation of trans-isomers of diphenylazetidinone derivatives |
| JP2007520453A (ja) * | 2003-11-10 | 2007-07-26 | マイクロビア インコーポレーテッド | ４−ビアリーリル−１−フェニルアゼチジン−２−オン |
| KR20080017345A (ko) * | 2005-05-11 | 2008-02-26 | 마이크로비아 인코포레이티드 | 페놀성 4-비페닐일아제티딘-2-온의 제조방법 |
-
2006
- 2006-05-05 TW TW095116021A patent/TW200726746A/zh unknown
- 2006-05-08 AU AU2006244212A patent/AU2006244212A1/en not_active Abandoned
- 2006-05-08 MX MX2007013872A patent/MX2007013872A/es unknown
- 2006-05-08 EP EP06759306A patent/EP1893571A2/en not_active Withdrawn
- 2006-05-08 JP JP2008510309A patent/JP2008542205A/ja active Pending
- 2006-05-08 WO PCT/US2006/017706 patent/WO2006122020A2/en active Application Filing
- 2006-05-08 KR KR1020077028441A patent/KR20080011687A/ko not_active Application Discontinuation
- 2006-05-08 US US11/913,587 patent/US20080287663A1/en not_active Abandoned
- 2006-05-08 CA CA002607939A patent/CA2607939A1/en not_active Abandoned
- 2006-05-08 EA EA200702428A patent/EA200702428A1/ru unknown
- 2006-05-08 BR BRPI0611045-2A patent/BRPI0611045A2/pt not_active Application Discontinuation
-
2007
- 2007-11-05 IL IL187155A patent/IL187155A0/en unknown
- 2007-11-29 NO NO20076161A patent/NO20076161L/no not_active Application Discontinuation
- 2007-11-30 MA MA30437A patent/MA29496B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006122020A2 (en) | 2006-11-16 |
| MX2007013872A (es) | 2008-04-02 |
| MA29496B1 (fr) | 2008-05-02 |
| BRPI0611045A2 (pt) | 2010-08-10 |
| KR20080011687A (ko) | 2008-02-05 |
| IL187155A0 (en) | 2008-02-09 |
| AU2006244212A1 (en) | 2006-11-16 |
| TW200726746A (en) | 2007-07-16 |
| JP2008542205A (ja) | 2008-11-27 |
| EA200702428A1 (ru) | 2008-04-28 |
| US20080287663A1 (en) | 2008-11-20 |
| EP1893571A2 (en) | 2008-03-05 |
| WO2006122020A3 (en) | 2007-05-18 |
| CA2607939A1 (en) | 2006-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20076371L (no) | Fremgangsmate for fremstilling av fenoliske 4-bifenylylazetidin-2-oner | |
| NO20084783L (no) | Syntese av acylaminoalkenylenamider nyttige som substans P antagonister | |
| EA200801608A1 (ru) | Производные бензимидазолонкарбоновой кислоты | |
| NO20074093L (no) | Fremgangsmater for fremstilling av glukopyranosyl-substituerte benzyl-benzenderivater og mellomprodukter derav | |
| EA200702614A1 (ru) | Способы получения 4-(бифенилил)азетидин-2-оналкилфосфиновых кислот | |
| NO20083427L (no) | Cystoksiske midler omfattende nye tomaymycinderivater og deres terapeutiske anvendelse | |
| EA201001683A1 (ru) | Производные фенил- или пиридинилзамещенных индазолов | |
| EA201000642A1 (ru) | 2'-фтор-2'-дезокситетрагидроуридины в качестве ингибиторов цитидиндеаминазы | |
| EA201200741A1 (ru) | Способ получения этексилата дабигатрана | |
| ES2338590T3 (es) | Procedimiento regioselectivo de preparacion de benzoimidazoltiofenos. | |
| ES2368594T3 (es) | Derivados sustituidos de ciclohexilmetilo. | |
| JO2947B1 (en) | Compounds corresponding to cyclopamine | |
| CY1109911T1 (el) | Πυρρολοβενζοδιαζεπινες | |
| NO20072963L (no) | 5-substituerte kinolin- og isokinolinderivater, fremgangsmate for deres fremstilling og deres anvendelse som betennelseshemmere | |
| NO20080129L (no) | Fremgangsmate for fremstilling av dihydrokinazoliner | |
| EA201070424A1 (ru) | Хиназолиндионовые производные, их получение и их применения в терапии | |
| EA200801145A1 (ru) | Спироциклические производные хиназолина в качестве ингибиторов pde7 | |
| ME00961B (me) | Derivati-7 alkinil-1,8-naftiridoni, njihova priprema i njihova primjena u liječenju | |
| EA200900090A1 (ru) | Бензиламины, способ их получения и их применение в качестве противовоспалительных средств | |
| NO20081206L (no) | Isoquinolines derivatives as IGF -1R inhibitors | |
| ATE517873T1 (de) | 6-oxo-1,6-dihydropyrimidin-2-yle bei der behandlung proliferativer krankheiten | |
| WO2008053334A3 (en) | An improved process for preparing rosuvastatin calcium | |
| NO20084301L (no) | Tetrahydronaftalenderivater, fremgangsmate for deres fremstilling og anvendelse derav som anti-inflammatoriske midler | |
| NO20085317L (no) | Imidazoazepinonforbindelser | |
| NO20074047L (no) | Ny fremgangsmate for fremstilling av substituerte indoler |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |